SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Credit Suisse Maintains Outperform on Globus Medical, Raises Price Target to $57

Credit Suisse maintains Globus Medical (NYSE:GMED) with a Outperform and raises the price target from $56 to $57.

Benzinga · 05/08/2020 14:30

Credit Suisse maintains Globus Medical (NYSE:GMED) with a Outperform and raises the price target from $56 to $57.